Geron Stock Surges After Encouraging Data From Rare Blood Cancer Trial
Geron Corporation (NASDAQ:GERN) announced topline results from its IMerge Phase 3 trial of imetelstat, in lower-risk myelodysplastic syndromes (MDS) patients who…
Why Oblong Shares Are Trading Higher By 59%; Here Are 20 Stocks Moving Premarket
Gainers
Elys Game Technology, Corp. (NASDAQ: ELYS) shares rose 63.2% to $0.4201 in pre-market trading after dropping 8% on Tuesday. Elys Game Technology and Cloakbook were recently granted a license to commence sportsbook operations in Washington, D.C.
Geron To Hold Conference Call For Top-Line Results From IMerge Phase 3 Clinical Trial On Jan. 4, 2023 At 8 a.m. EST
Geron Corporation (NASDAQ:GERN) today announced that it will host a conference call to discuss top-line results from the IMerge Phase 3 clinical trial of imetelstat, the Company's first-in-class telomerase inhibitor,
Recap: Geron Q3 Earnings
Geron (NASDAQ:GERN) reported its Q3 earnings results on Thursday, November 3, 2022 at 08:00 AM.
Here's what investors need to know about the announcement.
Earnings
Geron missed estimated earnings by 11.11%, reporting an EPS of $-0.1 versus an estimate of $-0.09.
Earnings Scheduled For November 3, 2022
Companies Reporting Before The Bell
• Hyatt Hotels (NYSE:H) is estimated to report quarterly earnings at $0.28 per share on revenue of $1.45 billion.
Earnings Preview: Geron
Geron (NASDAQ:GERN) is set to give its latest quarterly earnings report on Thursday, 2022-11-03. Here's what investors need to know before the announcement.
Analysts estimate that Geron will report an earnings per share (EPS) of $-0.09.
Marathon Digital, Coinbase Global And Some Other Big Stocks Moving Higher In Today’s Pre-Market Session
U.S. stock futures traded higher this morning after recording losses in the previous session. Here are some big stocks moving higher in today’s pre-market trading session.
Why Kiora Pharmaceuticals Is Trading Lower By Around 22%; Here Are 26 Stocks Moving Premarket
Gainers
9 Meters Biopharma, Inc. (NASDAQ: NMTR) rose 31.4% to $0.2720 in pre-market trading after the company disclosed final results from Phase 2 VIBRANT study, End-of-Phase 2 meeting with the FDA for Vurolenatide in short bowel syndrome.
10 Health Care Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.